Monophasic HA filler plus lidocaine corrects nasolabial folds

February 9, 2017

(HealthDay)—The monophasic hyaluronic acid (HA) filler with lidocaine, Dermalax implant plus (PLUS), is not inferior to the biphasic HA Restylane Sub-Q (Sub-Q) for correcting nasolabial folds (NLFs), according to a study published online Feb. 1 in the Journal of Cosmetic Dermatology.

Joon Hyuk Suh, M.D., from the Chung-Ang University College of Medicine in Seoul, South Korea, and colleagues enrolled 52 patients with visible NLFs in a randomized multicenter trial. Participants were injected with PLUS in one NLF and with Restylane Sub-Q in the other. Cosmetic changes were assessed in participants at two, eight, 12, 16, and 24 weeks. The 5-point Wrinkle Severity Rating Scale (WSRS) was used to rate wrinkle severity.

The researchers found that the mean improvement in the WSRS at week 24 versus baseline was 1.06 ± 0.54 and 0.69 ± 0.58 for the PLUS side and Sub-Q side, respectively. Within 30 minutes after the procedure, the average values of pain evaluated by self-assessment 100-mm visual analogue score scale were 14.65 ± 16.23 and 38.29 ± 27.27 in the PLUS and Sub-Q groups, respectively. Both fillers were well tolerated, with mild adverse reactions.

"We confirmed that the monophasic HA containing pre-incorporated lidocaine (PLUS) is not inferior to well-studied biphasic HA (Sub-Q) in correcting severe nasolabial folds for 24 weeks, and [is] less painful than biphasic HA not containing lidocaine," the authors write.

Explore further: Polycaprolactone efficient for nasolabial fold treatment

More information: Full Text (subscription or payment may be required)

Related Stories

Polycaprolactone efficient for nasolabial fold treatment

January 15, 2015
(HealthDay)—For patients with nasolabial folds (NLFs), treatment with a novel biostimulatory polycaprolactone (PCL)-based dermal filler is associated with improved long-lasting efficacy compared with nonanimal stabilized ...

Platelet-rich plasma injection reduces facial wrinkles

August 8, 2016
(HealthDay)—Platelet-rich plasma (PRP) intradermal injection can reduce wrinkles, especially wrinkles of the nasolabial folds (NLFs), according to a study published online July 29 in the Journal of Cosmetic Dermatology.

IV lidocaine has no meaningful impact in fibromyalgia

June 20, 2016
(HealthDay)—For patients with fibromyalgia, use of intravenous lidocaine has no meaningful impact, according to a study published online June 16 in the International Journal of Rheumatic Diseases.

Lidocaine/prilocaine optimal for deeper dermal laser procedures

July 14, 2016
(HealthDay)—For patients undergoing deeper dermal laser treatments of acne keloidalis nuchae (AKN) and tattoos, lidocaine/prilocaine cream is better for reducing pain than lidocaine/tetracaine cream, according to a study ...

Lidocaine, hyaluronidase mix works faster in myofascial pain

October 29, 2015
(HealthDay)—In patients with myofascial pain syndrome (MPS), trigger point injection (TPI) with lidocaine and hyaluronidase works more quickly on the first day following injection than lidocaine alone, but there are no ...

Recommended for you

Building better tiny kidneys to test drugs and help people avoid dialysis

February 16, 2018
A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies.

Expanding Hepatitis C testing to all adults is cost-effective and improves outcomes

February 16, 2018
According to a new study, screening all adults for hepatitis C (HCV) is a cost-effective way to improve clinical outcomes of HCV and identify more infected people compared to current recommendations. Using a simulation model, ...

Study suggests expanded range for emerging tick-borne disease

February 16, 2018
Human cases of Borrelia miyamotoi, a tick-borne infection with some similarities to Lyme disease, were discovered in the eastern United States less than a decade ago. Now new research led by the Yale School of Public Health ...

Flu shot only 36 percent effective, making bad year worse (Update)

February 15, 2018
The flu vaccine is doing a poor job protecting older Americans and others against the bug that's causing most illnesses.

IFN-mediated immunity to influenza A virus infection influenced by RIPK3 protein

February 15, 2018
Each year, influenza kills half a million people globally with the elderly and very young most often the victims. In fact, the Centers for Disease Control and Prevention reported 37 children have died in the United States ...

A new class of drug to treat herpes simplex virus-1 infection

February 14, 2018
For patients with the herpes simplex-1 virus (HSV-1), there are just a handful of drugs available to treat the painful condition that can affect the eyes, mouth and genitals.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.